Delivery Order SPE2DB20D1100-SPE2DB25FE4K0
- Not listed
- The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of ALBUKED-25 Vial 100ML pharmaceutical product. This competitively awarded, non-set-aside delivery order is scheduled for completion by September 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,650.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of August 21, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order valued at $1,140.75 to AmerisourceBergen Drug Corp for the supply of ALBUKED-25 VIAL 100ML, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $1,131.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of ALBUKED-25 vial 50ML pharmaceutical product. The contract, which is non-set-aside and competitively awarded, carries an ultimate completion date of August 1, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,320.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML, with an ultimate completion date of June 24, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $1 billion through December 2026. The product will be performed at AmerisourceBergen's corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.60 to AmerisourceBergen Drug Corp for ALBUKED-5 VIAL 250ML pharmaceutical products on September 11, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,563.00 by the Defense Logistics Agency on July 28, 2025, for the supply of ALBUKED-25 vial 100ML. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance is scheduled for completion by August 18, 2025, with work to be performed at the company's Conshohocken, PA location. This delivery order is a...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,740.75 to AmerisourceBergen Drug Corp on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a $15,484.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 6, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order calls for pharmaceutical products...
- The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $12,740 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, issued on June 18, 2025, with completion scheduled for June 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE4K0Delivery Order
The Defense Logistics Agency awarded a $1,368.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for pharmaceutical supplies, specifically ALBUKED-25 VIAL 100ML, with performance in Conshohocken, Pennsylvania and an ultimate completion date of September 24, 2025. This non-set-aside competitive award was issued on September 3, 2025, and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant $1 billion IDC with DLA Troop Support Medical (designated SPE2DX) through December 2026, which serves as the comprehensive vehicle for global pharmaceutical support to military healthcare programs. This delivery order exemplifies the company's critical role in supplying medical commodities—including specialty medications, vaccines, and medical supplies—to the Defense Health Agency and other federal healthcare systems. The contract reflects DLA's strategy to leverage prime vendor relationships for flexible, efficient procurement of essential pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/3/25 |